Franklin Resources Inc Acadia Pharmaceuticals Inc Transaction History

Franklin Resources Inc

  • $378 Billion
  • Q3 2025

A detailed history of Franklin Resources Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 378,484 shares of ACAD stock, worth $9.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
378,484
Previous 155,241 143.8%
Holding current value
$9.09 Million
Previous $3.35 Million 141.22%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$20.88 - $26.57 $4.66 Million - $5.93 Million
223,243 Added 143.8%
378,484 $8.08 Million
Q2 2025

Aug 12, 2025
SELL
$14.1 - $22.95 $246,623 - $401,418
-17,491 Reduced 10.13%
155,241 $3.35 Million
Q1 2025

May 13, 2025
SELL
$16.61 - $20.29 $135,138 - $165,079
-8,136 Reduced 4.5%
172,732 $2.87 Million
Q4 2024

Feb 12, 2025
SELL
$14.29 - $18.76 $115,706 - $151,899
-8,097 Reduced 4.28%
180,868 $3.32 Million
Q3 2024

Nov 12, 2024
SELL
$15.14 - $19.14 $3,436 - $4,344
-227 Reduced 0.12%
188,965 $2.91 Million
Q2 2024

Aug 14, 2024
BUY
$14.62 - $18.42 $595,194 - $749,896
40,711 Added 27.42%
189,192 $3.07 Million
Q1 2024

May 13, 2024
BUY
$17.79 - $30.86 $1.74 Million - $3.03 Million
98,076 Added 194.58%
148,481 $2.75 Million
Q4 2023

Feb 09, 2024
BUY
$20.78 - $31.77 $16,686 - $25,511
803 Added 1.62%
50,405 $1.58 Million
Q3 2023

Nov 13, 2023
BUY
$20.84 - $33.47 $45,806 - $73,567
2,198 Added 4.64%
49,602 $1.03 Million
Q2 2023

Aug 11, 2023
BUY
$17.8 - $25.65 $295,088 - $425,225
16,578 Added 53.78%
47,404 $1.14 Million
Q1 2023

May 12, 2023
SELL
$16.32 - $20.92 $8,241 - $10,564
-505 Reduced 1.61%
30,826 $580,000
Q4 2022

Feb 10, 2023
SELL
$14.2 - $18.63 $6,191 - $8,122
-436 Reduced 1.37%
31,331 $498,000
Q3 2022

Nov 14, 2022
BUY
$14.11 - $18.27 $236,130 - $305,748
16,735 Added 111.33%
31,767 $520,000
Q2 2022

Aug 11, 2022
SELL
$13.01 - $27.22 $40,122 - $83,946
-3,084 Reduced 17.02%
15,032 $212,000
Q1 2022

May 13, 2022
BUY
$20.94 - $27.5 $28,645 - $37,620
1,368 Added 8.17%
18,116 $439,000
Q4 2021

Feb 11, 2022
BUY
$16.79 - $27.09 $281,198 - $453,703
16,748 New
16,748 $391,000
Q3 2021

Nov 12, 2021
SELL
$15.78 - $24.77 $11.2 Million - $17.6 Million
-711,711 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$19.4 - $27.42 $39,711 - $56,128
2,047 Added 0.29%
711,711 $17.4 Million
Q1 2021

May 13, 2021
SELL
$25.02 - $54.99 $19,215 - $42,232
-768 Reduced 0.11%
709,664 $18.3 Million
Q4 2020

Feb 10, 2021
BUY
$41.04 - $56.79 $25,732 - $35,607
627 Added 0.09%
710,432 $38 Million
Q3 2020

Nov 12, 2020
BUY
$36.42 - $57.0 $1.21 Million - $1.89 Million
33,215 Added 4.91%
709,805 $29.3 Million
Q4 2019

Feb 12, 2020
SELL
$36.21 - $51.4 $2.65 Million - $3.76 Million
-73,200 Reduced 9.76%
676,590 $28.9 Million
Q1 2019

May 14, 2019
BUY
$16.17 - $27.38 $11.6 Million - $19.7 Million
719,396 Added 2366.9%
749,790 $20.1 Million
Q4 2018

Feb 12, 2019
BUY
$14.32 - $22.92 $435,242 - $696,630
30,394 New
30,394 $491,000
Q2 2018

Aug 14, 2018
SELL
$15.07 - $22.34 $32.6 Million - $48.4 Million
-2,166,346 Closed
0 $0
Q1 2018

May 10, 2018
SELL
$22.47 - $32.33 $24.1 Million - $34.6 Million
-1,071,500 Reduced 33.09%
2,166,346 $48.7 Million
Q4 2017

Feb 14, 2018
BUY
$26.84 - $39.14 $4.54 Million - $6.62 Million
169,057 Added 5.51%
3,237,846 $97.5 Million
Q3 2017

Nov 13, 2017
BUY
$29.49 - $38.37 $90.5 Million - $118 Million
3,068,789
3,068,789 $116 Million

Others Institutions Holding ACAD

# of Institutions
373
Shares Held
162M
Call Options Held
1.46M
Put Options Held
1.09M
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.89B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email